HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands

• Published in: Molecular membrane biology Vol. 16; no. 1; pp. 49 - 55
• Main Authors: Clapham, Paul R., Reeves, Jacqueline D., Simmons, Graham, Dejucq, Natalie, Hibbitts, Sam, Aine, McKnight
• Format: Journal Article
• Language: English
• Published: England Informa UK Ltd 1999; Taylor & Francis
• Subjects: CD4 Antigens - physiology; Hiv Tropism;Hiv Receptors; Humans; Models, Biological; Receptors, CCR5 - physiology; Receptors, Chemokine - physiology; Receptors, HIV - physiology; Tropism - physiology
• ISSN: 0968-7688; 1464-5203
• DOI: 10.1080/096876899294751

HIV is a persistent virus that survives and replicates despite an onslaught by the host's immune system. A strategy for cell entry, requiring the use of two receptors, has evolved that may help evade neutralizing antibodies. HIV and SIV usually require both CD4 and a seven transmembrane (7TM) coreceptor for infection. At least eleven different 7TM coreceptors have been identified that confer HIV and/ or SIV entry. For HIV-1, the major coreceptors are CCR5 and CXCR4, while the role of other coreceptors for replication and cell tropism in vivo is currently unclear. Polymorphisms in the CCR5 gene that reduce CCR5 expression levels, protect against disease progression, suggesting that drugs targeted to CCR5 could be effective. Such therapies however will not work if HIV simply adapts to use alternative coreceptors. In the light of these themes, this review will discuss the following topics: (i) the coreceptors used by primary HIV-1 and HIV-2 viruses, (ii) the properties and coreceptors of HIV-2 strains that infect cells without CD4, (iii) the role of coreceptors in HIV cell tropism and particularly macrophage infection and (iv) the properties of chemokine receptor ligands that block HIV infection.